| Modality | Indication | Current Stage | Development Partners | ||||
|---|---|---|---|---|---|---|---|
| Discovery | Pre-clinical | Phase 1 | Phase 2 | Phase 3 | |||
| Cancer | |||||||
| Vaccine | Breast Cancer |
|
|
|
|
||
| Vaccine | Ovarian Cancer |
|
|
|
|||
| Vaccine | Lung, Colon, and Prostate Cancers |
|
|
||||
| CAR-T | Ovarian Cancer |
|
|
|
|
||
| CAR-T | Other solid tumors |
|
|
||||
Latest News & Events
Anixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology
Read More...Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial
Read More...Anixa Biosciences to Host an Investor Webcast on June 26, 2025
Read More...